首页> 外文会议>SPIE Conference on Microfluidics, BioMEMS, and Medical Microsystems >Cell-based quantification of biomarkers from an ultra-fast microfluidic immunofluorescent staining: application to breast cancer cell lines
【24h】

Cell-based quantification of biomarkers from an ultra-fast microfluidic immunofluorescent staining: application to breast cancer cell lines

机译:来自超快速微流体免疫荧光染色的基于细胞的生物标志物的定量:在乳腺癌细胞中施用

获取原文
获取外文期刊封面目录资料

摘要

Immunohistochemistry (IHC) is one of the main techniques currently used in the clinics for biomarker character-ization. It consists in colorimetric labeling with specific antibodies followed by microscopy analysis. The results are then used for diagnosis and therapeutic targeting. Well-known drawbacks of such protocols are their limited accuracy and precision, which prevent the clinicians from having quantitative and robust IHC results. With our work, we combined rapid microfluidic immunofluorescent staining with efficient image-based cell segmentation and signal quantification to increase the robustness of both experimental and analytical protocols. The exper-imental protocol is very simple and based on fast-fluidic-exchange in a microfluidic chamber created on top of the formalin-fixed-paraffin-embedded (FFPE) slide by clamping it a silicon chip with a polydimethyl siloxane (PDMS) sealing ring. The image-processing protocol is based on enhancement and subsequent thresholding of the local contrast of the obtained fluorescence image. As a case study, given that the human epidermal growth factor receptor 2 (HER.2) protein is often used as a biomarker for breast cancer, we applied our method to HER2+ and HER2- cell lines. We report very fast (5 minutes) immunofluorescence staining of both HER2 and cytokeratin (a marker used to define the tumor region) on FFPE slides. The image-processing program can segment cells correctly and give a cell-based quantitative immunofluorescent signal. With this method, we found a good separation between positive and negative control samples in the biomarker expression space.
机译:免疫组织化学(IHC)是目前用于生物标志物特征诊所的主要技术之一。它包括具有特异性抗体的比色标记,然后是显微镜分析。然后将结果用于诊断和治疗靶向。这些方案的众所周知的缺点是它们有限的精度和精度,这防止临床医生具有定量和稳健的IHC结果。通过我们的作品,我们将快速的微流体免疫荧光染色与高效的图像基细胞分割和信号量化组合,以增加实验和分析方案的鲁棒性。通过将硅芯片夹紧在具有聚二甲基硅氧烷(PDMS)密封的硅芯片上,基于在福尔马林固定石蜡嵌入式(FFPE)的顶部产生的微流体室中的微流体室中的微流体腔室中的微流体交换非常简单,基于快速流体交换戒指。图像处理协议基于所获得的荧光图像的局部对比度的增强和随后的阈值处理。作为一个案例研究,鉴于人表皮生长因子受体2(HER.2)蛋白通常用作乳腺癌的生物标志物,我们将我们的方法应用于HER2 +和HER2-细胞系。我们在FFPE载玻片上报告了HER2和细胞角蛋白(用于定义肿瘤区域的标记物)的免疫荧光染色非常快(5分钟)免疫荧光染色。图像处理程序可以正确地分段细胞并给出基于细胞的定量免疫荧光信号。通过这种方法,我们发现生物标志物表达空间中的阳性和阴性对照样品之间的良好分离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号